Norton, Larry (October 2021) IS THE MAXIMUM TOLERATED DOSE (MDT) STILL THE OPTIMAL GOAL FOR CANCER DRUGS? In: UNSPECIFIED.
| Item Type: | Conference or Workshop Item (Paper) |
|---|---|
| Subjects: | diseases & disorders > cancer > cancer types > breast cancer diseases & disorders > cancer > drugs and therapies |
| CSHL Authors: | |
| Communities: | CSHL labs > Wigler lab |
| SWORD Depositor: | CSHL Elements |
| Depositing User: | CSHL Elements |
| Date: | October 2021 |
| Date Deposited: | 02 Nov 2021 15:42 |
| Last Modified: | 02 Nov 2021 15:43 |
| Related URLs: | |
| URI: | https://repository.cshl.edu/id/eprint/40404 |
Actions (login required)
 |
Administrator's edit/view item |
